[go: up one dir, main page]

NO20076515L - Hydantoinforbindelser - Google Patents

Hydantoinforbindelser

Info

Publication number
NO20076515L
NO20076515L NO20076515A NO20076515A NO20076515L NO 20076515 L NO20076515 L NO 20076515L NO 20076515 A NO20076515 A NO 20076515A NO 20076515 A NO20076515 A NO 20076515A NO 20076515 L NO20076515 L NO 20076515L
Authority
NO
Norway
Prior art keywords
hydantoin
treating
useful
formula
relates
Prior art date
Application number
NO20076515A
Other languages
English (en)
Inventor
Mark Spyvee
Shawn Schiller
Eric Carlson
Qian Chen
Heather Davis
Jr Brian M Gallagher
Christina Shaffer
Nancy Wong
Original Assignee
Eisai Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai Co Ltd filed Critical Eisai Co Ltd
Publication of NO20076515L publication Critical patent/NO20076515L/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/10—Spiro-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Rheumatology (AREA)
  • Immunology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Oppfinnelsen vedrører anvendelse av hydantoinforbindelser i følge formel I som er nyttige for å behandle eller forhindre autoimmune forstyrrelser. Foreliggende oppfinnelse tilveiebringer også sammensetninger og anvendelser derav. (I)
NO20076515A 2005-05-27 2007-12-19 Hydantoinforbindelser NO20076515L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US68559405P 2005-05-27 2005-05-27
PCT/US2006/020848 WO2006128143A2 (en) 2005-05-27 2006-05-26 Hydantoin compounds

Publications (1)

Publication Number Publication Date
NO20076515L true NO20076515L (no) 2007-12-19

Family

ID=37189015

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20076515A NO20076515L (no) 2005-05-27 2007-12-19 Hydantoinforbindelser

Country Status (15)

Country Link
US (2) US7666875B2 (no)
EP (2) EP1888583A2 (no)
JP (1) JP2008542304A (no)
KR (1) KR20080013931A (no)
CN (1) CN101263141A (no)
AU (1) AU2006251947A1 (no)
BR (1) BRPI0609895A2 (no)
CA (1) CA2609270A1 (no)
DE (1) DE06771541T1 (no)
IL (1) IL187279A0 (no)
MX (1) MX2007014888A (no)
NO (1) NO20076515L (no)
RU (1) RU2007149327A (no)
TW (1) TW200724140A (no)
WO (1) WO2006128143A2 (no)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds
US7985746B2 (en) 2006-05-26 2011-07-26 Eisai R&D Management Co., Ltd. Imidazoazepinone compounds
WO2007139948A2 (en) * 2006-05-26 2007-12-06 Eisai R & D Management Co., Ltd Imidazoazepinone compounds
MX2008015037A (es) * 2006-05-26 2008-12-10 Eisai R&D Man Co Ltd Compuestos de imidazoazepinona.
US20100298342A1 (en) * 2006-09-07 2010-11-25 Merck & Co., Inc. Spiropiperidine beta-secretase inhibitors for the treatment of Alzheimer's Disease
EP2217242A1 (en) * 2007-11-15 2010-08-18 Eisai R&D Management Co., Ltd. Methods of use
WO2009064274A1 (en) * 2007-11-15 2009-05-22 Eisai R & D Management Co., Ltd. Enantiomerically enriched imidazoazepinone compounds
US20110065916A1 (en) * 2007-11-26 2011-03-17 Mark Spyvee Method of making imidazoazepinone compounds
MA40532A (fr) 2014-08-28 2021-04-28 Asceneuron Sa Inhibiteurs de glycosidases
US11261183B2 (en) 2016-02-25 2022-03-01 Asceneuron Sa Sulfoximine glycosidase inhibitors
MX381953B (es) 2016-02-25 2025-03-13 Asceneuron S A Sales de derivados de piperazina obtenidas por adicion de acidos.
US11612599B2 (en) 2016-02-25 2023-03-28 Asceneuron Sa Glycosidase inhibitors
CN113166083A (zh) 2018-08-22 2021-07-23 阿森纽荣股份公司 用作糖苷酶抑制剂的哌嗪衍生物的琥珀酸盐和富马酸盐酸加成盐
US11731972B2 (en) * 2018-08-22 2023-08-22 Asceneuron Sa Spiro compounds as glycosidase inhibitors
US12016852B2 (en) 2018-08-22 2024-06-25 Asceneuron Sa Pyrrolidine glycosidase inhibitors
WO2020039028A1 (en) 2018-08-22 2020-02-27 Asceneuron S. A. Tetrahydro-benzoazepine glycosidase inhibitors
WO2024092040A1 (en) * 2022-10-26 2024-05-02 Protego Biopharma, Inc. Spirocycle containing bicyclic heteroaryl compounds

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US685594A (en) 1901-04-19 1901-10-29 Frank A Franklin Pulp-washing machine.
JP4710606B2 (ja) * 2003-04-18 2011-06-29 小野薬品工業株式会社 スピロピペリジン化合物およびその医薬用途
EP1786816A4 (en) * 2003-09-10 2009-11-04 Virochem Pharma Inc SPIROHYDANTOIN COMPOUNDS AND METHODS FOR MODULATING CHEMOKINE RECEPTOR ACTIVITY
US7709642B2 (en) 2004-06-25 2010-05-04 Virochem Pharma, Inc. Spirohydantoin compounds and methods for the modulation of chemokine receptor activity
TW200724140A (en) * 2005-05-27 2007-07-01 Eisai Co Ltd Hydantoin compounds

Also Published As

Publication number Publication date
WO2006128143A3 (en) 2007-03-29
CA2609270A1 (en) 2006-11-30
TW200724140A (en) 2007-07-01
BRPI0609895A2 (pt) 2011-10-11
MX2007014888A (es) 2008-02-19
JP2008542304A (ja) 2008-11-27
CN101263141A (zh) 2008-09-10
US20100113446A1 (en) 2010-05-06
IL187279A0 (en) 2008-02-09
DE06771541T1 (de) 2008-09-11
RU2007149327A (ru) 2009-07-10
US7666875B2 (en) 2010-02-23
AU2006251947A1 (en) 2006-11-30
KR20080013931A (ko) 2008-02-13
EP2336131A1 (en) 2011-06-22
EP1888583A2 (en) 2008-02-20
WO2006128143A2 (en) 2006-11-30
US20060270696A1 (en) 2006-11-30

Similar Documents

Publication Publication Date Title
NO20076515L (no) Hydantoinforbindelser
HUS2100051I1 (hu) Kompozíciók és eljárások sejtproliferációs rendellenességek kezelésére
NO20070487L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
NO20081421L (no) Midler for hindring og behandling av forstyrrelser som involverer modulering av RYR-reseptorer
NO20070933L (no) Indazoler anvendbare i behandling av kardiovaskulaere sykdommer
EA201070238A1 (ru) Соединения пиримидина
NO20070489L (no) 3-aminocyklopentankarboksamider som modulatorer av kjemokinreseptorer.
EA200870292A1 (ru) Соединения на основе имидазола, композиции, содержащие их, и способы их применения
NO20084489L (no) Azolopyrimidiner som inhibitorer av cannabinoid 1 aktivitet
TW200714604A (en) Substituted heterocycles and the uses thereof
NO20076059L (no) 2,4-Diamino-pyrimidiner anvendt som aurorainhibitorer
EA200900828A1 (ru) Соединения и композиции в качестве ингибиторов активности каннабиноидного рецептора 1
NO20074941L (no) Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier
NO20070049L (no) Pyrrolotriazinderivater anvendelig for behandling av hyperproliferative forstyrrelser og sykdommer assosiert med angiogenese
NO20063449L (no) Substituerte heterocykler og deres anvendelse
WO2007070434A3 (en) Fused aminopiperidines as dipeptidyl peptidase-4 inhibitors for the treatment or prevention of diabetes
NO20082285L (no) 3-aminosyklopentankarboksamider som modulatorer av kjemokinreseptorer
SE0403006D0 (sv) New compounds
NO20071378L (no) Tiazolo-naftylsyrer.
WO2007079214A3 (en) Prokineticin 2 receptor antagonists
NO20064325L (no) Heteroarylaminopyrazolderivativer nyttige for behandling av diabetes
NO20065678L (no) 3-(4-heteroarylcykloheksylamino) cyklopentankarboksamider som modulatorer for kjemokinreseptorer.
MX2007011847A (es) Derivados de pirimidindiona como antagonistas del receptor de procineticina 2.
DE60329326D1 (de) Tace inhibitoren
ATE474834T1 (de) Als agonisten des gpr38-rezeptors geeignete biarylverbindungen

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application